For general wellness, a monthly shot might be enough
DOZA supplies BPC-157 in pre-mixed pen format manufactured by Pen Peptide: 5 mg (200 clicks, 1 click = 25 mcg) in stabilized MSSPT (Molecular Structure Stabilization Process Technology) form
Clinical Background BPC-157 was introduced in 1993 and initially studied as a potential treatment for inflammatory bowel disease due to its anti-ulcer effects
GLOBAL GLUTATHIONE MARKET SIZE, BY BEVERAGES, 2018-2032 (USD MILLION) TABLE 48
Comparison CompoundClassPathway / targetResearch focusFormat SemaxACTH-fragment peptideBDNF / NGF signallingNeurotrophic & cognitive researchVial SelankAnxiolytic peptide (Tuftsin analogue)GABA-BDNF interplayNeuropeptide / anxiolytic-model researchVial Semax + SelankPeptide blendCombined BDNF/NGF & GABA pathwaysComparative neuropeptide researchVial CerebrolysinMulti-peptide preparationNeurotrophic factor signallingNeurotrophic-pathway researchVial P21 (P021)Neurotrophic peptideTrkB receptorBDNF-mimetic signalling researchVial DihexaPeptidomimetic (small molecule)HGF / c-Met pathwaySynaptogenesis researchCapsules J-147Small moleculeMitochondrial / neurotrophic signallingNeuroprotective-model researchCapsules 9-Me-BCSmall molecule (beta-carboline)GDNF / dopaminergic pathwayNeurotrophic-model researchCapsules Methylene BlueSmall molecule (phenothiazine)Mitochondrial electron transport chainOxidative-stress & metabolism researchCapsules DSIPSleep-regulatory peptideDelta-wave / neuroendocrine axisSleep-signalling researchVial Every compound in this category is supplied as Research Use Only material with: Peer-reviewed literature underpinning this category
Sikiric P, Separovic J, Buljat G, Anic T, Stancic-Rokotov D, Mikus D, Marovic A, Prkacin I, Duplancic B, Zoricic I, Aralica G, Lovric-Bencic M, Ziger T, Perovic D, Rotkvic I, Mise S, Hanzevacki M, Hahn V, Seiwerth S, Turkovic B, Grabarevic Z, Petek M, Rucman R
